VANCOUVER BUSINESS REPORTSBusiness in Vancouver Reports on Verisante
May 3, 2011
Business in Vancouver reporter Nelson Bennett writes:
The Canadian Institutes of Health Research (CIHR) has approved a $292,000 grant to the BC Cancer Agency, which in turn will use the money to help the company finalize testing and optimization of its Verisante Aura device. As part of the funding arrangement, Verisante will contribute $303,800.
Thomas Braun, president and CEO of Verisante, said the grant not only helps the company financially, it also helps lend credibility to its technology.
“Some people think that it’s quite important in terms of validating the technology,” he told Business in Vancouver.
The Verisante Aura uses a pen-sized spectroscope that scans the skin and can detect cancer bio-markers. A positive reading tells the physician the patient should have a biopsy. Negative readings would mean many costly biopsies could be avoided.
Read the entire article on our website at:
https://verisante.com/news/media/
do your own due diligence
herb